CIK: 0001910264
Total reported value
$915.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 43.88% | +7.77% | — | |
| 2 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 10.32% | -3.10% | — | |
| 3 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 10.07% | -4.55% | — | |
| 4 | DSGN | Design Therapeutics INC | Stock-Other | 9.82% | -1.08% | — | |
| 5 | ZBIO | Zenas Biopharma INC | Stock-Other | 9.81% | -15.14% | — | |
| 6 | MLYS | Mineralys Therapeutics INC | Stock-Other | 6.05% | -3.40% | — | |
| 7 | ALMS | Alumis INC | Stock-Other | 3.76% | +2.01% | — | |
| 8 | ORKA | Oruka Therapeutics INC | Stock-Other | 2.03% | +0.46% | +14.65% | |
| 9 | NKTX | Nkarta INC | Stock-Other | 2.02% | -0.10% | — | |
| 10 | ✓ | Engene Holdings INC | Stock-Other | 1.21% | -0.40% | — | |
| 11 | KALAEUR | Kala Bio INC | Stock-Other | 1.01% | — | +35.00% |